Delivery Order SPE2DE22D0008-SPE2D626F44S3
Award Date 12/19/25
Potential Completion Date 2/26/26
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,115.79 to Alba Bioscience, Inc. for the ALBACYTE Antibody ID Panel (16-Cell) on October 30, 2025, with an ultimate completion date of January 7, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier of immunohematology reagents and blood banking diagnostic materials. Alba Bioscience, a...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded Alba Bioscience, Inc. a $9,500 delivery order on October 30, 2025, for an ALBACYTE Antibody ID Panel (10-Cell) with a completion date of January 7, 2026. This firm fixed-price delivery order represents a competitive procurement without set-aside designation, leveraging Alba Bioscience's specialized capabilities in immunohematology reagents and blood banking diagnostics. Alba Bioscience, a Chicago-based subsidiary of...
- Alba Bioscience, Inc. was awarded a delivery order valued at $6,270 on September 4, 2025, for the ALBACYTE Antibody ID Panel (10-Cell) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The contract is scheduled for completion by November 7, 2025, and will be performed at the contractor's facility in Chicago, Illinois. This non-set-aside award represents Alba Bioscience's continued role as a critical supplier of specialized in vitro diagnostic...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,150 to Alba Bioscience, Inc. for ALBACYTE Antibody Screen (2-Cell) products, with an ultimate completion date of October 9, 2025. Alba Bioscience, a Chicago-based supplier of in vitro diagnostics and blood bank reagents, was selected through a non-set-aside competitive process. The delivery order falls under the company's existing blanket purchase agreements with the Department of Veterans Affairs, which...
- Alba Bioscience, Inc., a Chicago-based supplier of in vitro diagnostics and blood bank reagents, was awarded a delivery order for ALBACYTE Antibody ID Panel (10-Cell) on June 2, 2025, with a ceiling value of $12,895. The contract is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and was issued without a set-aside designation, indicating competitive procurement. The award was funded by the Defense Logistics Agency's Medical Supply Chain division,...
- Alba Bioscience, Inc. was awarded a delivery order valued at $1,123.00 by the Medical Supply Chain division of the Defense Department on July 29, 2025, with an ultimate completion date of August 1, 2025. The contract, identified as 4568920078, covers the supply of ALBACLONE Anti-A antibodies, specialized reagents used in blood banking and immunohematology testing. This non-set-aside award was issued under a firm fixed-price arrangement, with performance to be completed in Chicago, Illinois. Alba...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,370.00 to Alba Bioscience, Inc. for ALBACLONE Anti-A antibodies, with performance completion targeted for August 19, 2025. This non-set-aside contract represents a firm fixed price delivery order for specialized blood banking diagnostic reagents to be delivered to Chicago, Illinois. Alba Bioscience, a foreign-owned subsidiary of Quotient Biodiagnostics, Inc., has established itself as a critical...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,123.00 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-D Blend, a monoclonal antibody product used in immunohematology and blood banking operations. The contract is firm fixed-price with no set-aside designation and an ultimate completion date of December 22, 2025. Alba Bioscience, a Chicago-based for-profit subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,080 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-E monoclonal antibodies under a firm fixed price contract. The award, issued on October 30, 2025, with an ultimate completion date of November 4, 2025, represents a competitive procurement with no set-aside designation. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and...
- Alba Bioscience, Inc. was awarded a delivery order contract on July 15, 2025, for ALBACLONE Anti-K antibodies with a firm fixed price ceiling value of $3,400. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed in Chicago, Illinois, with an ultimate completion date of July 18, 2025. This non-set-aside award recognizes Alba Bioscience's established position as a critical supplier of in vitro diagnostic reagents and blood bank products to...